{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:33:35Z","timestamp":1772433215836,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1006\/clim.2001.5039","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:45:11Z","timestamp":1032191111000},"page":"49-56","source":"Crossref","is-referenced-by-count":55,"title":["Cytokine and Chemokine Dysregulation in Hyper-IgE Syndrome"],"prefix":"10.1006","volume":"100","author":[{"given":"Jihed","family":"Chehimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Elder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenora","family":"Noroski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.Richard","family":"Stiehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry A.","family":"Winkelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen E.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clim.2001.5039_RF1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/peds.49.1.59","article-title":"Extreme hyperimmunoglobulinemia E and undue susceptibility to infection","volume":"49","author":"Buckley","year":"1972","journal-title":"Pediatrics"},{"key":"10.1006\/clim.2001.5039_RF2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","article-title":"Job's syndrome: Recurrent, \u201ccold,\u201d staphylococcal abscesses","volume":"1","author":"Davis","year":"1966","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5039_RF3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections\u2014An autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2001.5039_RF4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1081-1206(10)63204-8","article-title":"Cyclosporin A in hyperimmunoglobulin E syndrome","volume":"78","author":"Etzioni","year":"1997","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1006\/clim.2001.5039_RF5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(96)91603-7","article-title":"Cyclosporin treatment of hyperimmunoglobulin E syndrome","volume":"347","author":"Wolach","year":"1996","journal-title":"Lancet"},{"key":"10.1006\/clim.2001.5039_RF6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/07853899708999334","article-title":"Type 1 and type 2 cytokines in HIV infection\u2014A possible role in apoptosis and disease progression","volume":"29","author":"Clerici","year":"1997","journal-title":"Ann. Med."},{"key":"10.1006\/clim.2001.5039_RF7","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/aid.1996.12.1255","article-title":"Virologic and immunologic markers of disease progression in pediatric HIV infection","volume":"12","author":"Vigano","year":"1996","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1006\/clim.2001.5039_RF8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4049\/jimmunol.162.2.1056","article-title":"IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC\/Nga mice, a model for human atopic dermatitits","volume":"162","author":"Matsumoto","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5039_RF9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2249.1995.tb05574.x","article-title":"The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response\u2014An in vivo model of Th2-like activity","volume":"99","author":"Bundick","year":"1995","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clim.2001.5039_RF10","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1172\/JCI114618","article-title":"Regulation of immunoglobulin (Ig) E synthesis in the hyper-IgE syndrome","volume":"85","author":"Vercelli","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clim.2001.5039_RF11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1081-1206(10)63143-2","article-title":"Interleukin 4 and interferon-g secretion by antigen and mitogen stimulated mononuclear cells in the hyper-IgE syndrome: No TH-2 cytokine pattern","volume":"81","author":"Rodriguez","year":"1998","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1006\/clim.2001.5039_RF12","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1172\/JCI114368","article-title":"Defective in vitro production of g-interferon and tumor necrosis factor-a by circulating T cells from patients with hyperimmunoglobulin E syndrome","volume":"84","author":"Del Prete","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clim.2001.5039_RF13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0022-3476(00)70098-9","article-title":"Defective interleukin-12\/interferon-gamma pathway in patients with hyperimmunoglobulinemia E syndrome","volume":"136","author":"Borges","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1006\/clim.2001.5039_RF14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clin.1995.1090","article-title":"Cytokine-mediated bone resorption in patients with the hyperimmunoglobulin E syndrome","volume":"76","author":"Cohen-Solal","year":"1995","journal-title":"Clin. Immunol. Immunopath."},{"key":"10.1006\/clim.2001.5039_RF15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3476(05)82151-1","article-title":"Use of recombinant human inteferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections","volume":"118","author":"Jeppson","year":"1991","journal-title":"J. Pediatr."},{"key":"10.1006\/clim.2001.5039_RF16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/jir.1998.18.561","article-title":"Recombinant IFN-g treatment of a patient with hyperimmunoglobulin E syndrome triggered autoimmune thrombocytopenia","volume":"18","author":"Aihara","year":"1998","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1006\/clim.2001.5039_RF17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-6749(99)70510-5","article-title":"Regulation of immunoglobulin production in hyper-IgE (Job's) syndrome","volume":"103","author":"Garraud","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1006\/clim.2001.5039_RF18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/aid.1996.12.1141","article-title":"Differential production of interleukin 10 during human immunodeficiency virus infection","volume":"12","author":"Chehimi","year":"1996","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1006\/clim.2001.5039_RF19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/eji.1830230814","article-title":"Enhancing effect of natural killer cell stimulatory factor (NKSF\/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells","volume":"23","author":"Chehimi","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clim.2001.5039_RF20","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.179.4.1361","article-title":"Impaired interleukin 12 production in human immunodeficiency virus-infected patients","volume":"179","author":"Chehimi","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.2001.5039_RF21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/blood.V94.3.1003.415a15_1003_1011","article-title":"The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals","volume":"94","author":"Marshall","year":"1999","journal-title":"Blood"},{"key":"10.1006\/clim.2001.5039_RF22","first-page":"1678","article-title":"Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: Ability to maintain IFN-gamma induction is associated with clinical response","volume":"6","author":"Gollob","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1006\/clim.2001.5039_RF23","first-page":"3983","article-title":"Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer","volume":"5","author":"Portielje","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1006\/clim.2001.5039_RF24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1086\/302547","article-title":"Genetic linkage of hyper-IgE syndrome to chromosome 4","volume":"65","author":"Grimbacher","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1006\/clim.2001.5039_RF25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0091-6749(95)70185-0","article-title":"High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome","volume":"95","author":"Kimata","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1006\/clim.2001.5039_RF26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0091-6749(91)90126-9","article-title":"Antibody responses to protein, polysaccharide, and fX174 antigens in the hyperimmunoglobulin E (hyper-IgE) syndrome","volume":"87","author":"Sheerin","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1006\/clim.2001.5039_RF27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/0091-6749(88)90873-1","article-title":"Impaired antibody responses in the hyperimmunoglobulin E syndrome","volume":"81","author":"Leung","year":"1988","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1006\/clim.2001.5039_RF28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0889-8588(18)30632-4","article-title":"Clinical and immunologic aspects of the hyperimmunoglobulin E syndrome","volume":"2","author":"Leung","year":"1988","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1006\/clim.2001.5039_RF29","first-page":"129","article-title":"Hyperimmunoglobin E syndrome: A sign of TH1\/TH2 imbalance?","volume":"9","author":"Shirafuji","year":"1999","journal-title":"Eur. J. Dermatol."},{"key":"10.1006\/clim.2001.5039_RF30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0091-6749(91)90213-8","article-title":"Shifts in interleukin-4 and interferon-gamma production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis","volume":"87","author":"Rousset","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1006\/clim.2001.5039_RF31","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.4049\/jimmunol.164.6.3009","article-title":"Selective suppression of IL-12 production by chemoattractants","volume":"164","author":"Braun","year":"2000","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5039_RF32","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/sj.bmt.1702446","article-title":"Bone marrow transplantation does not correct the hyper-IgE syndrome","volume":"25","author":"Gennery","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1006\/clim.2001.5039_RF33","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.287.5454.860","article-title":"Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity","volume":"287","author":"Ashkar","year":"2000","journal-title":"Science"},{"key":"10.1006\/clim.2001.5039_RF34","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1128\/IAI.67.8.4223-4230.1999","article-title":"Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin","volume":"67","author":"Nau","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2001.5039_RF35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1359\/jbmr.1998.13.7.1101","article-title":"Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro","volume":"13","author":"Rittling","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/clim.2001.5039_RF36","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1172\/JCI2131","article-title":"Altered wound healing in mice lacking a functional osteopontin gene (Supp. 1)","volume":"101","author":"Liaw","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clim.2001.5039_RF37","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.2648569","article-title":"The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes","volume":"243","author":"Larsen","year":"1989","journal-title":"Science"},{"key":"10.1006\/clim.2001.5039_RF38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1165\/ajrcmb.17.2.2818","article-title":"Human endothelial cells synthesize ENA-78: Relationship to IL-8 and to signaling of PMN adhesion","volume":"17","author":"Imaizumi","year":"1997","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661601950399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661601950399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T05:15:25Z","timestamp":1680585325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661601950399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S1521661601950399"],"URL":"https:\/\/doi.org\/10.1006\/clim.2001.5039","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}